Literature DB >> 11835931

Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes.

Torbjørn Omland1, James A de Lemos, David A Morrow, Elliot M Antman, Christopher P Cannon, Christian Hall, Eugene Braunwald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11835931     DOI： 10.1016/s0002-9149(01)02271-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  22 in total

1.  Serial NT-proBNP measurements for risk stratification of patients with decompensated heart failure.

Authors:  C Lüers; A Schmidt; R Wachter; F Fritzsche; A Sutcliffe; S Kleta; A Zapf; G Hagenah; L Binder; B Maisch; B Pieske
Journal:  Herz       Date:  2010-10       Impact factor: 1.443

2.  N-terminal pro-BNP in acute coronary syndrome patients with ST elevation (STE-ACS) versus non ST elevation (NSTE-ACS).

Authors:  Ragaa Salama; Alaa El-Moniem; Nour El-Hefney; Tarek Samor
Journal:  Int J Health Sci (Qassim)       Date:  2011-07

3.  A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes.

Authors:  Gjin Ndrepepa; Siegmund Braun; Julinda Mehilli; Kathrin Niemöller; Albert Schömig; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2006-10-30       Impact factor: 5.460

4.  Association of somatic and cognitive depressive symptoms and biomarkers in acute myocardial infarction: insights from the translational research investigating underlying disparities in acute myocardial infarction patients' health status registry.

Authors:  Kim G Smolderen; John A Spertus; Kimberly J Reid; Donna M Buchanan; Viola Vaccarino; Judith H Lichtman; David B Bekelman; Paul S Chan
Journal:  Biol Psychiatry       Date:  2011-09-08       Impact factor: 13.382

5.  B-Type Natriuretic Peptide (BNP) and Left Ventricular (LV) Function in Patients with ST-Segment Elevation Myocardial Infarction (STEMI).

Authors:  Maria Dorobantu; Ana-Gabriela Fruntelata; Alexandru Scafa-Udriste; Oana-Florentina Tautu
Journal:  Maedica (Buchar)       Date:  2010-12

6.  N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure.

Authors:  C Fisher; C Berry; L Blue; J J Morton; J McMurray
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

7.  B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study.

Authors:  Kirsten Bibbins-Domingo; Maria Ansari; Nelson B Schiller; Barry Massie; Mary A Whooley
Journal:  Circulation       Date:  2003-12-08       Impact factor: 29.690

8.  N-TerminaL PRO-BNP in Acute Coronary Syndrome Patients with ST Elevation Versus Non ST Elevation in Qassim Region of Saudi Arabia.

Authors:  Ragaa H M Salama; Alaa E A El-Moniem; Nour El-Hefney; Tarek Samor
Journal:  Int J Health Sci (Qassim)       Date:  2011-07

Review 9.  B-type natriuretic peptide in ischemic heart disease.

Authors:  Rajat Deo; James A de Lemos
Journal:  Curr Cardiol Rep       Date:  2003-07       Impact factor: 2.931

10.  Ischemia/reperfusion is an independent trigger for increasing myocardial content of mRNA B-type natriuretic peptide.

Authors:  Lafayete William F Ramos; Neif Murad; Eduardo Goto; Edinei L Antônio; José A Silva; Paulo F Tucci; Antônio C Carvalho
Journal:  Heart Vessels       Date:  2009-11-22       Impact factor: 2.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.